Chief Financial Officer Mark Ragosa of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) filed a Form 4 on September 3, 2026, reporting multiple transactions dated September 1, 2026, including restricted share unit vestings, a share withholding disposal, and new equity awards.
Key Highlights
- RSU Vestings: Ragosa converted a total of 9,104 restricted share units into Class A Ordinary Shares across four separate transactions, all dated September 1, 2026.
- Shares Withheld for Taxes: 4,404 Class A Ordinary Shares were disposed of at $79.28 per share under transaction code F, reducing holdings to 20,854 directly owned shares.
- New RSU Grant: 7,800 new restricted share units were awarded on September 1, 2026, vesting 25% annually over four years from the grant date.
- New Share Option Grant: 31,150 share options were awarded with an exercise price of $79.28, vesting 25% on the first anniversary of September 1, 2026 and then in 36 equal monthly installments, expiring August 31, 2036.
- Post-Transaction Ownership: Following all reported transactions, Ragosa directly holds 20,854 Class A Ordinary Shares and 21,938 total derivative securities including RSUs and options.
RSU Vestings, New Awards, and Share Withholding for Kiniksa CFO
According to the filing, Ragosa's September 1, 2026 activity involved four RSU vesting events tied to grants made on September 1, 2022, September 1, 2023, September 1, 2024, and September 1, 2025. The shares acquired through vesting were 2,694, 1,750, 1,591, and 3,069 Class A Ordinary Shares, respectively, each converting from RSUs at a price footnoted as no cash consideration. As each tranche vested, Ragosa's directly held share count stepped up sequentially to 18,848, then 20,598, then 22,189, and then 25,258 shares before the tax withholding transaction.
The filing reports a disposition of 4,404 Class A Ordinary Shares at $79.28 per share under transaction code F, which the filing associates with tax withholding on vesting. After this disposal, Ragosa's direct beneficial ownership stood at 20,854 Class A Ordinary Shares, according to the filing. On the same date, two new awards were reported: a grant of 7,800 RSUs vesting equally over four annual anniversaries of September 1, 2026, and a grant of 31,150 share options at an exercise price of $79.28, with a vesting commencement date of September 1, 2026 and an expiration date of August 31, 2036.
The filing notes that each RSU represents a contingent right to receive one Class A Ordinary Share. Following all reported transactions, the derivative securities beneficially owned directly by Ragosa include 9,206 RSUs from the September 1, 2025 grant, 3,182 RSUs from the September 1, 2024 grant, 1,750 RSUs from the September 1, 2023 grant, 7,800 newly granted RSUs, and 31,150 newly granted share options, per the filing.
What Was Disclosed
The Form 4 discloses RSU vestings, a tax-related share disposal at $79.28 per share, and new grants of 7,800 RSUs and 31,150 share options to Kiniksa's Chief Financial Officer, all transacted on September 1, 2026.




Please wait processing your request...